Thoracic radiotherapy for limited-stage small-cell lung cancer: Controversies and future developments

Corinne Faivre-Finn, L. W. Lee, P. Lorigan, C. West, N. Thatcher

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Thoracic radiotherapy has an established role in the management of limited-disease small-cell lung cancer (LD SCLC). However, essential questions relating to the optimisation of thoracic radiotherapy remain unanswered, including volume of irradiation, optimal total dose, fractionation, timing and sequencing of radiation. This review highlights the need for well-designed multi-national trials aimed at the optimisation and standardisation of radiotherapy for LD SCLC. © 2005 Published by Elsevier Ltd on behalf of the Royal College of Radiologists.
    Original languageEnglish
    Pages (from-to)591-598
    Number of pages7
    JournalClinical Oncology
    Volume17
    Issue number8
    DOIs
    Publication statusPublished - Dec 2005

    Keywords

    • Radiotherapy
    • Review
    • Small-cell lung carcinoma
    • Thoracic

    Fingerprint

    Dive into the research topics of 'Thoracic radiotherapy for limited-stage small-cell lung cancer: Controversies and future developments'. Together they form a unique fingerprint.

    Cite this